<MedlineCitation Status="Completed">
<MedlineID>10011747</MedlineID>
<PMID>421064</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0007-1447</ISSN>
<JournalIssue>
<Volume>1</Volume>
<Issue>6158</Issue>
<PubDate>
<Year>1979</Year>
<Month>Jan</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Tranexamic acid in chronic urticaria.</ArticleTitle>
<Pagination>
<MedlinePgn>266</MedlinePgn>
</Pagination>
<AuthorList>
<Author>
<LastName>Tant</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Br Med J</MedlineTA>
<NlmUniqueID>0372673</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cyclohexanecarboxylic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1197-18-8</RegistryNumber>
<NameOfSubstance>Tranexamic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Cyclohexanecarboxylic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Tranexamic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Urticaria</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
